Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (6356)	1/19/1999 11:59:00 PM
From: Vector1	Read Replies (2) \| Respond to of 9719

Miljenko, With all due respect, cash is always an issue for a biotech with less than two years of cash. There are a number of institutional healthcare investors who simply will not invest under those circumstances. The markets are fickle. Sometimes the window for financing is open and sometimes it is not for development stage biotechs. For the last 6 months the window has largley been closed. I believe things are changing and beleive there is a high likelihood that CELG will get a new round of institutional capital. I would like to see the terms before I buy the stock again. V1